60 related articles for article (PubMed ID: 21846577)
21. Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia.
Pakakasama S; Kanchanakamhaeng K; Kajanachumpol S; Udomsubpayakul U; Sirachainan N; Thithapandha A; Hongeng S
Ann Hematol; 2007 Aug; 86(8):609-11. PubMed ID: 17323057
[No Abstract] [Full Text] [Related]
22. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
Joannon P; Oviedo I; Campbell M; Tordecilla J
Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
[TBL] [Abstract][Full Text] [Related]
23. Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.
Shuper A; Stark B; Kornreich L; Cohen IJ; Avrahami G; Yaniv I
Isr Med Assoc J; 2002 Nov; 4(11):1050-3. PubMed ID: 12489505
[TBL] [Abstract][Full Text] [Related]
24. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952
[TBL] [Abstract][Full Text] [Related]
25. Liquoral myelin basic protein in acute lymphoblastic leukemia.
Pagano L; Marra R; Massaro AR; Carbone G; Storti S; Leone G
Eur J Haematol; 1989 Apr; 42(4):407-8. PubMed ID: 2470616
[No Abstract] [Full Text] [Related]
26. Acute and long-term neurologic complications in children with acute lymphoblastic leukemia.
Aytaç S; Yetgin S; Tavil B
Turk J Pediatr; 2006; 48(1):1-7. PubMed ID: 16562778
[TBL] [Abstract][Full Text] [Related]
27. Intrathecal methotrexate-induced acute cerebellar syndrome.
Ferhanoglu B; Ongören S; Ar CM; Uzel B; Forta H; Necioglu D
Ann Hematol; 2003 Apr; 82(4):241-3. PubMed ID: 12707728
[TBL] [Abstract][Full Text] [Related]
28. Cerebrospinal fluid levels of markers of brain parenchymal damage in Vietnamese adults with severe malaria.
Medana IM; Lindert RB; Wurster U; Hien TT; Day NP; Phu NH; Mai NT; Chuong LV; Chau TT; Turner GD; Farrar JJ; White NJ
Trans R Soc Trop Med Hyg; 2005 Aug; 99(8):610-7. PubMed ID: 15935412
[TBL] [Abstract][Full Text] [Related]
29. Low incidence of CNS relapse with cranial radiotherapy and intrathecal methotrexate in acute lymphoblastic leukemia.
Raje NS; Vaidya SJ; Kapoor G; Pai SK; Nair CN; Kurkure PA; Magrath IT; Advani SH
Indian Pediatr; 1996 Jul; 33(7):556-60. PubMed ID: 8979564
[TBL] [Abstract][Full Text] [Related]
30. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
31. The impact of high-dose methotrexate on intracellular 6-mercaptopurine disposition during interval therapy of childhood acute lymphoblastic leukemia.
Adam de Beaumais T; Dervieux T; Fakhoury M; Medard Y; Azougagh S; Zhang D; Yakouben K; Jacqz-Aigrain E
Cancer Chemother Pharmacol; 2010 Sep; 66(4):653-8. PubMed ID: 20033410
[TBL] [Abstract][Full Text] [Related]
32. Glioblastoma multiforme following prophylactic cranial irradiation and intrathecal methotrexate in a child with acute lymphoblastic leukaemia : a case report.
Muzumdar DP; Desai K; Goel A
Neurol India; 1999 Jun; 47(2):142-4. PubMed ID: 10402343
[TBL] [Abstract][Full Text] [Related]
33. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.
Hill JM; Kornblith AB; Jones D; Freeman A; Holland JF; Glicksman AS; Boyett JM; Lenherr B; Brecher ML; Dubowy R; Kung F; Maurer H; Holland JC
Cancer; 1998 Jan; 82(1):208-18. PubMed ID: 9428499
[TBL] [Abstract][Full Text] [Related]
34. Elevation of neuron-specific enolase and S-100beta protein level in experimental acute spinal cord injury.
Cao F; Yang XF; Liu WG; Hu WW; Li G; Zheng XJ; Shen F; Zhao XQ; Lv ST
J Clin Neurosci; 2008 May; 15(5):541-4. PubMed ID: 18343116
[TBL] [Abstract][Full Text] [Related]
35. Level of tau protein in children treated for acute lymphoblastic leukemia.
Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas PT; Hołownia A
Pediatr Neurol; 2006 May; 34(5):367-71. PubMed ID: 16647996
[TBL] [Abstract][Full Text] [Related]
36. Correlation of cerebrospinal fluid beta-glucuronidase activity with plasma methotrexate concentrations in leukemic children receiving high-dose methotrexate.
Vlacha V; Eliopoulou M; Haidas S; Beratis NG
Pediatr Blood Cancer; 2004 Apr; 42(4):350-6. PubMed ID: 14966832
[TBL] [Abstract][Full Text] [Related]
37. [Study on elimination delay in high dose methotrexate therapy in childhood acute lymphoblastic leukemia].
Xu WQ; Tang YM; Fang CQ; Song H; Shi SW; Yang SL; Ren DT; Shen HQ; Qian BQ
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):15-8. PubMed ID: 15946502
[TBL] [Abstract][Full Text] [Related]
38. F2-isoprostanes: a measure of oxidative stress in children receiving treatment for leukemia.
Hockenberry MJ; Taylor OA; Gundy PM; Ross AK; Pasvogel A; Montgomery D; Ribbeck P; McCarthy K; Moore I
Biol Res Nurs; 2014 Jul; 16(3):303-9. PubMed ID: 23956352
[TBL] [Abstract][Full Text] [Related]
39. Brain white matter changes during treatment of a child for acute lymphoblastic leukemia.
Maeda M; Hayakawa J; Ueda T; Migita M; Asano T; Fukunaga Y; Amano Y
J Nippon Med Sch; 2005 Oct; 72(5):252-3. PubMed ID: 16247223
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-6-Mediated Inflammation May Cause Methotrexate-Induced Leukoencephalopathy.
Asano T; Iguchi A; Miyasho T
J Interferon Cytokine Res; 2020 Jul; 40(7):341-348. PubMed ID: 32614271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
